Ignite Creation Date:
2025-12-25 @ 12:17 AM
Ignite Modification Date:
2025-12-25 @ 10:19 PM
Study NCT ID:
NCT06216158
Status:
RECRUITING
Last Update Posted:
2025-12-03
First Post:
2024-01-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
Sponsor:
University of Heidelberg Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-05
Start Date Type:
ACTUAL
Primary Completion Date:
2028-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-09
First Submit QC Date:
None
Study First Post Date:
2024-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-25
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED